Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma

GSK authors: Kristin Morris, Pharm.D; Farrah Pompilus, PhD; Amy Phillips-Jones, MSc; Giulia Fulci, PhD; Neal Sule, MB; Brandon E. Kremer, MD; PhD; Joanna Opalinska, MD, PhD